2020年印度制药行业展望 -印度品牌价值基金会（英文版）（35页）.pdf

1、For updated information, please visit www.ibef.org August 2020 PHARMACEUTICALS Table of Contents Executive Summary.3 Advantage India.4 Market Overview .6 Recent trends and Strategies.14 Growth Drivers.18 Opportunities.28 Useful Information.30 For updated information, please visit www.ibef.orgPharmac

2、euticals 3 EXECUTIVE SUMMARY Source: 1 FICCI - Trends domestic generic drug market is expected to reach US$ 27.9 billion in 2020 Due to their competence in generic drugs, growth in this market offers a great opportunity for Indian firms Based on moving annual turnover, Anti-Infectives (13.6%), Cardi

3、ac (12.4%), Gastro Intestinals (11.5%) had the biggest market share in the Indian pharma market in 2018. The highest growth in sales in 2018 were seen in hormones (14.2%), anti diabetic (12.9%), and respiratory (12%). During December 2019, on moving annual total (MAT) basis, industry growth was at 9

4、.8 per cent, with price growth at 5.3 per cent, new product growth at 2.7 per cent while volume growth at two per cent y-o-y. 0.41 0.91 0.31 0.34 0.35 0.95 1.14 1.27 1.29 1.43 1.61 1.78 2.17 2.34 2.58 Others Vaccines Hormones Ophthal Anti-Neoplastics Gynaecological Neuro / Cns Derma Pain / Analgesic

5、s Respiratory Vitamins / Minerals Anti Diabetic Gastro Intestinal Cardiac Anti-Infectives Segment Wise Moving Annual Turnover2 2018 (US$ billion) For updated information, please visit www.ibef.orgPharmaceuticals 11 PHARMA EXPORT TO CONTINUE WITNESSING POSITIVE GROWTH 32.1% 18.0% 15.7% 6.9% 6.8% 5.6%

6、 14.9% North America Africa EU ASEAN LAC Middle East Others Source: Department of Commerce India, Department of Pharmaceuticals, India Business News, Global Trade Atlas, KPMG US-India Dynamic June 2018, Pharmexcil India is the worlds largest provider of generic medicines; the countrys generic drugs